GlassScriptPhysician profile
Jason A Rytlewski
NPI 1104036029
$33,929.93
in general payments reported to CMS, 2019-2025
28 companies · $3,759 in 2025
The $3,759 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,124 · 2020: $463 · 2021: $759 · 2022: $5,193 · 2023: $7,893 · 2024: $7,739 · 2025: $3,759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,439 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,200 · Consulting Fee: $3,450 · Travel and Lodging: $3,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,439.43 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,200.00 |
| Consulting Fee | $3,450.00 |
| Travel and Lodging | $3,301.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $19,005.48 | 2019-2025 | Biomonitor, Rivacor 7 Dr-T, Acticor 7 Vr-T Dx |
| Medtronic Vascular, INC. | $5,564.01 | 2019 | |
| Biosense Webster, INC. | $1,994.64 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro |
| Medtronic, INC. | $1,531.34 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Evera Mri Xt Dr Surescan, Azure Xt Dr Mri Surescan |
| Medical Device Business Services, INC. | $1,335.44 | 2023 | Carto 3 |
| Boston Scientific Corporation | $1,334.44 | 2019-2024 | Watchman Flx, Rotapro, Versacross Access Solution |
| Abbott Laboratories | $974.79 | 2019-2023 | Ensite Precision |
| Atricure, INC. | $611.65 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| E.R. Squibb & Sons, L.L.C. | $196.19 | 2022-2025 | Eliquis, Camzyos |
| Amgen INC. | $188.41 | 2019-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $163.16 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $147.24 | 2020-2025 | Wainua |
| Novartis Pharmaceuticals Corporation | $135.78 | 2019-2024 | |
| Acutus Medical, INC. | $122.15 | 2019 | |
| Cardiva Medical, INC. | $91.78 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $84.13 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.01 | 2020-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $60.94 | 2024 | Arcalyst |
| Merck Sharp & Dohme LLC | $49.67 | 2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.40 | 2020 | |
| Edwards Lifesciences Corporation | $40.94 | 2022-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Esperion Therapeutics, INC. | $34.00 | 2021 | |
| Alnylam Pharmaceuticals INC. | $33.37 | 2025 | Amvuttra |
| Kiniksa Pharmaceuticals, LTD. | $29.62 | 2021 | |
| Janssen Pharmaceuticals, INC | $27.99 | 2023 | Xarelto |
| Astellas Pharma US INC | $22.56 | 2021 | |
| Novo Nordisk INC | $16.97 | 2024 | Ozempic |
| Heartflow, INC. | $9.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Rytlewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.